Session » Abstracts: Miscellaneous Rheumatic & Inflammatory Diseases II
- 11:00AM-12:30PM
-
Abstract Number: 2659
A Comprehensive Approach Utilizing a Combination of Genetics, Cytological Analysis, and Imaging Techniques to Speed up the Diagnostic Process in VEXAS Patients
- 11:00AM-12:30PM
-
Abstract Number: 2663
ADI-001: An Allogeneic CD20-targeted γδ CAR T Cell Therapy with Potential for Improved Tissue Homing in Autoimmune Indications
- 11:00AM-12:30PM
-
Abstract Number: 2664
BCMA-targeted Bispecific T Cell-engager Therapy of Autoimmune Disease
- 11:00AM-12:30PM
-
Abstract Number: 2661
Changes in Krebs Von Den Lungen 6 Levels (∆KL6) Predict Fibrosing Progression of Interstitial Lung Disease in Patients with an Underlying Connective Tissue Disease (CTD-ILD)
- 11:00AM-12:30PM
-
Abstract Number: 2660
Developing Predictive Models for the Diagnosis of VEXAS Syndrome
- 11:00AM-12:30PM
-
Abstract Number: 2662
In Vivo Generation of B Cell Depleting CAR T Cell Therapies for Treatment of Autoimmune Diseases